The results of two clinical studies, PROUD and IPERGAY, suggests that the use of pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM) is an effective HIV prevention tool for Europe.
On the occasion of World AIDS Day, ECDC launched the latest surveillance data on HIV in the European Region. 2014 theme: 10 years of data show that Europe is not curbing the epidemic
The use of pre-exposure prophylaxis (PrEP) as an HIV prevention strategy, particularly among men who have sex with men (MSM) as well as other population groups at higher risk of HIV infection, has been receiving more and more attention during 2014. Preliminary results of clinical trials and research studies suggest that it could be an effective HIV prevention tool for Europe.
From 21 to 28 November 2014, nearly 700 organisations across Europe will host activities to increase awareness of the personal and public health benefits of HIV testing. As HIV infection can remain asymptomatic for a long time and a substantial number of infected persons across Europe are unaware of their infection, ECDC supports the aims of this second European HIV testing week.
The U.S. Centers for Disease Control and Prevention published clinical practice guidelines on pre-exposure prophylaxis (PrEP) for the prevention of HIV. In EU, most countries lack implementation data and formal licensure and guidelines.
Monitoring and responding to HIV and hepatitis C among people who inject drugs is the focus of two new reports from the EU drugs agencies EMCDDA and ECDC.
World AIDS Day was introduced by the World Health Organization in 1988 and is observed on 1 December each year to raise awareness of the AIDS pandemic caused by HIV infection.
According to new data published today by ECDC and the WHO Regional Office for Europe, more than 131 000 new HIV infections were reported in the WHO European Region in 2012, 10 000 (8%) more than in 2011. Of these new HIV infections, the countries of the European Union and European Economic Area (EU/EEA) accounted for more than 29 000 new HIV infections.
From 22 to 29 November 2013, the first European HIV testing week will take place with more than 400 organisations across Europe hosting activities to increase awareness of the benefits of HIV testing.
ECDC today publishes a first set of reports illustrating how countries have been responding to HIV up till 2012 based on their commitment outlined in the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia. The reports find that, on balance, political leadership in response to HIV is rather strong in the countries of the region.